Human regenerating (Reg) gene products are regionally expressed by gut-derived tissues, and are markedly up-regulated in cancer and in diseases characterized by mucosal injury. We recently identified Reg IV, a novel regenerating gene product that is uniquely expressed by the normal distal gastrointestinal mucosa. The function remains poorly understood due to the lack of significant purified Reg IV for biochemical and functional studies. Recombinant human Reg IV was efficiently expressed under the control of the AOX1 gene promoter in Pichia pastoris using the Muts strain KM71H. We describe the unique conditions that are required for efficient production of Reg IV protein in high density fermentation. Optimal protein expression was obtained by reduction of the fermentation temperature and addition of casamino acids as a supplemental nitrogen source and to minimize the activity of yeast produced proteases. Recombinant Reg IV protein was purified by tangential flow filtration and reverse phase chromatography. The purified protein was characterized by amino terminus sequence analysis and MALDI-TOFMS showing that the engineered protein had the expected sequence and molecular weight without secondary modification. Recombinant Reg IV was further characterized by specific monoclonal and polyclonal reagents that function for Western blot analysis and for immunolocalization studies.

Original languageEnglish
Pages (from-to)197-206
Number of pages10
JournalProtein Expression and Purification
Issue number2
StatePublished - Oct 2003


  • Colorectal adenocarcinoma
  • Inflammatory bowel disease
  • Lithostathine family
  • Mucosal injury
  • Reg
  • Reg IV
  • Regenerating gene


Dive into the research topics of 'Expression of a novel regenerating gene product, Reg IV, by high density fermentation in Pichia pastoris: Production, purification, and characterization'. Together they form a unique fingerprint.

Cite this